Skip to main content

Tucuvi

Category: AI in Healthcare

A clinical conversational AI platform that automates medical phone consultations to monitor and care for patients at scale. Tucuvi was founded in 2019. The company is led by María González Manso. Based in Madrid, Spain. Team size: 11-50. Total funding raised: $26.0M. Latest round: Series A ($20.0M, Oct 2024). Key investors include ["Cathay Health","Leadwind (K Fund)","Seaya Ventures","Frontline Ventures","Shilling","Ship2B Ventures"].

Founded
2019
Headquarters
Madrid, Spain
Team size
11-50
Total funding
$26.0M

Value proposition

Increases clinical capacity and reduces healthcare costs by automating routine patient follow-ups via voice AI, ensuring high adherence among elderly patients without requiring smartphones or apps.

Products and solutions

["LOLA: The core clinical conversational AI virtual assistant for voice-based patient interaction.","Clinical Dashboard: A real-time monitoring interface for healthcare professionals to review patient alerts and structured data.","Chronic Disease Management Modules: Specialized protocols for Heart Failure, COPD, and Hypertension.","Post-Surgical Follow-up: Automated outreach programs to monitor recovery and prevent readmissions.","Life Sciences Solutions: Tools for clinical trial patient monitoring and real-world evidence collection."]

Unique value

Unlike most digital health tools that rely on apps, Tucuvi uses phone-based voice AI, making it accessible to the elderly and non-tech-savvy populations who are the highest users of healthcare.

Target customer

Public and private healthcare providers, hospitals, health insurers, and life sciences companies.

Industries served

["Healthcare Services","Digital Health","Telemedicine","Life Sciences & Pharmaceuticals"]

Technology advantage

Proprietary Natural Language Processing (NLP) specifically trained on clinical terminology and diverse accents, integrated directly into healthcare workflows and Electronic Health Records (EHR).

How they differentiate

Tucuvi differentiates through a 'voice-first' phone-based approach that eliminates the need for smartphones or apps, making it uniquely accessible to elderly populations. Its proprietary NLP is specifically trained on clinical terminology and regional accents to ensure medical-grade accuracy.

Main competitors

["Corti","Care Angel","Sensely"]

Key partnerships

["Major Spanish Hospitals (e.g., Hospital Universitario La Paz, Hospital Ramón y Cajal)","National Health Service (NHS) UK trusts","Cathay Health & Seaya Ventures (Strategic Investors)","Pharmaceutical companies for clinical trial monitoring"]

Notable customers

["National Health Service (NHS) UK","Hospital Universitario La Paz","Hospital Ramón y Cajal","Sanitas"]

Major milestones

["Successfully expanded operations from Spain into the UK healthcare market (2023)","CEO María González Manso named in Forbes 30 Under 30 Europe 2025","Closed $20M Series A led by Cathay Health to scale AI care management (Oct 2024)","Reached milestone of 1 million patient interactions via 'Lola' AI"]

Growth metrics

Automated over 1 million clinical conversations; deployed in 40+ hospitals and healthcare organizations.

Market positioning

Specialized clinical conversational AI provider for chronic disease management and post-surgical follow-up.

Geographic focus

Europe (primarily Spain, United Kingdom, and Portugal)

Patents and IP

Proprietary clinical AI engine and structured data extraction algorithms (specific public patent filings not disclosed in Series A announcement).

About María González Manso

María is a Biomedical Engineer with a focus on healthcare innovation. Before co-founding Tucuvi, she worked at Medtronic in the Diabetes division, specializing in marketing and business innovation. She also served as an Entrepreneur in Residence at Demium Startups, where she began developing the concept for Tucuvi to address healthcare accessibility through AI.

Official website: